Ohad Amit

982 total citations
11 papers, 556 citations indexed

About

Ohad Amit is a scholar working on Statistics and Probability, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Ohad Amit has authored 11 papers receiving a total of 556 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Statistics and Probability, 3 papers in Molecular Biology and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Ohad Amit's work include Statistical Methods in Clinical Trials (4 papers), Phosphodiesterase function and regulation (3 papers) and Health Systems, Economic Evaluations, Quality of Life (2 papers). Ohad Amit is often cited by papers focused on Statistical Methods in Clinical Trials (4 papers), Phosphodiesterase function and regulation (3 papers) and Health Systems, Economic Evaluations, Quality of Life (2 papers). Ohad Amit collaborates with scholars based in United States, United Kingdom and Switzerland. Ohad Amit's co-authors include Mary E. Strek, Stephen I. Rennard, Neil Schachter, Kathy Rickard, Jeffrey D. Helterbrand, William D. Bushnell, A Stone, C.H. Compton, G. Schultze‐Werninghaus and Jon G. Ayres and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and Clinical Infectious Diseases.

In The Last Decade

Ohad Amit

11 papers receiving 524 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ohad Amit United States 9 244 169 147 125 87 11 556
Sally Worsley United Kingdom 13 256 1.0× 217 1.3× 99 0.7× 88 0.7× 36 0.4× 24 548
J. O’Shaughnessy United States 9 69 0.3× 66 0.4× 183 1.2× 149 1.2× 34 0.4× 11 512
Anja Schiel Norway 13 89 0.4× 53 0.3× 150 1.0× 35 0.3× 125 1.4× 24 582
Felipe Melo Cruz Brazil 13 279 1.1× 23 0.1× 122 0.8× 354 2.8× 16 0.2× 40 674
Zhimin Yang China 11 86 0.4× 26 0.2× 72 0.5× 129 1.0× 22 0.3× 25 397
P. Stattin Sweden 7 257 1.1× 32 0.2× 186 1.3× 184 1.5× 14 0.2× 17 512
Bas Peters Netherlands 15 149 0.6× 16 0.1× 94 0.6× 167 1.3× 19 0.2× 38 464
Xiaofei F. Wang United States 14 254 1.0× 51 0.3× 150 1.0× 283 2.3× 32 0.4× 31 638
Michael Palmer United States 8 166 0.7× 25 0.1× 83 0.6× 164 1.3× 14 0.2× 9 362
Lise Matzke Canada 10 30 0.1× 142 0.8× 113 0.8× 33 0.3× 19 0.2× 24 461

Countries citing papers authored by Ohad Amit

Since Specialization
Citations

This map shows the geographic impact of Ohad Amit's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ohad Amit with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ohad Amit more than expected).

Fields of papers citing papers by Ohad Amit

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ohad Amit. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ohad Amit. The network helps show where Ohad Amit may publish in the future.

Co-authorship network of co-authors of Ohad Amit

This figure shows the co-authorship network connecting the top 25 collaborators of Ohad Amit. A scholar is included among the top collaborators of Ohad Amit based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ohad Amit. Ohad Amit is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Kraker, Marlieke E.A. de, Harriet Sommer, Femke de Velde, et al.. (2018). Optimizing the Design and Analysis of Clinical Trials for Antibacterials Against Multidrug-resistant Organisms: A White Paper From COMBACTE’s STAT-Net. Clinical Infectious Diseases. 67(12). 1922–1931. 27 indexed citations
2.
Mannino, Frank, Ohad Amit, & Soumi Lahiri. (2013). Evaluation of Discordance Measures in Oncology Studies with Blinded Independent Central Review of Progression-Free Survival Using an Observational Error Model. Journal of Biopharmaceutical Statistics. 23(5). 971–985. 3 indexed citations
3.
Stone, A, William D. Bushnell, Daniel J. Sargent, et al.. (2011). Research outcomes and recommendations for the assessment of progression in cancer clinical trials from a PhRMA working group. European Journal of Cancer. 47(12). 1763–1771. 42 indexed citations
4.
Amit, Ohad, Frank Mannino, A Stone, et al.. (2011). Blinded independent central review of progression in cancer clinical trials: Results from a meta-analysis. European Journal of Cancer. 47(12). 1772–1778. 78 indexed citations
5.
Amit, Ohad, et al.. (2010). Blinded Independent Central Review of the Progression-Free Survival Endpoint. The Oncologist. 15(5). 492–495. 29 indexed citations
6.
Slamon, Dennis J., Henry Gómez, Fairooz F. Kabbinavar, et al.. (2008). Randomized study of pazopanib + lapatinib vs. lapatinib alone in patients with HER2-positive advanced or metastatic breast cancer. Journal of Clinical Oncology. 26(15_suppl). 1016–1016. 70 indexed citations
7.
Amit, Ohad, Richard M. Heiberger, & P. W. Lane. (2007). Graphical approaches to the analysis of safety data from clinical trials. Pharmaceutical Statistics. 7(1). 20–35. 35 indexed citations
8.
Rennard, Stephen I., Neil Schachter, Mary E. Strek, Kathy Rickard, & Ohad Amit. (2006). Cilomilast for COPD. CHEST Journal. 129(1). 56–66. 87 indexed citations
9.
10.
Compton, C.H., Richard Nieman, Jeffrey D. Edelson, et al.. (2001). Cilomilast, a selective phosphodiesterase-4 inhibitor for treatment of patients with chronic obstructive pulmonary disease: a randomised, dose-ranging study. The Lancet. 358(9278). 265–270. 152 indexed citations
11.
Goldberg, Michael R., Man‐Wai Lo, David D. Christ, et al.. (1997). DuP 532, an angiotensin II receptor antagonist: First administration and comparison with losartan*. Clinical Pharmacology & Therapeutics. 61(1). 59–69. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sally Worsley Breakdown of academic impact, for papers by J. O’Shaughnessy Breakdown of academic impact, for papers by Anja Schiel Breakdown of academic impact, for papers by Felipe Melo Cruz Breakdown of academic impact, for papers by Zhimin Yang Breakdown of academic impact, for papers by P. Stattin Breakdown of academic impact, for papers by Bas Peters Breakdown of academic impact, for papers by Xiaofei F. Wang Breakdown of academic impact, for papers by Michael Palmer Breakdown of academic impact, for papers by Lise Matzke
Rankless by CCL
2026